Search Results 1901-1910 of 17045 for pharmacogenetics
Learn about the expertise and services, including travel medicine, offered at Mayo Clinic to people with concerns about infectious diseases.
This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive ...
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could affect ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic researchers are using technology to produce tissue models of different body parts to study damaged or diseased tissues and organs. They envision a[.
Imagine knowing your risk for disease long before symptoms appear. With early detection and targeted interventions, this knowledge could transform how complex ...
Early detection improves treatment outcomes for endometrial and ovarian cancers, yet far too often women are diagnosed in advanced stages of these diseases.
Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...
Learn about navigating regulatory pathways that advance promising biotherapies to daily patient care at RegenBio Summit: Transforming Next-Gen ...
Mayo Clinic Q&A podcast: COVID-19 vaccine trials update featured image · Early-stage clinical trial provides hope for patients with traumatic spinal cord ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.